Aurbindo got MCC approval

Hyderabad based Aurobindo Pharma has received approvals from the Medicines Control Council (MCC) to manufacture and market nine products in South Africa. These products are estimated to have a generic market size of ZAR 165 million in the local market The following products received approval from MCC:
1) Auro-Lisinopril Co (CVS)
2) Auro-Amlodipine (CVS)
3) Auro-Finasterid (BPH)
4) Zinoxime (anti-infective)
5) Zolid (CNS)
6) Yomax (anti-infective)
7) Lazivir (ARV)
8) Lisinozide (CVS)
9) Profina (BPH)